Sandford D Smith - Net Worth and Insider Trading
Sandford D Smith Net Worth
The estimated net worth of Sandford D Smith is at least $788,616 dollars as of 2024-04-26. Sandford D Smith is the Director of Cytokinetics Inc and owns about 12,170 shares of Cytokinetics Inc (CYTK) stock worth over $788,616. Sandford D Smith is also the Director of Aegerion Pharmaceuticals Inc and owns about 0 shares of Aegerion Pharmaceuticals Inc (AEGR) stock worth over $0. Details can be seen in Sandford D Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandford D Smith has not made any transactions after 2022-09-02 and currently still holds the listed stock(s).
Transaction Summary of Sandford D Smith
Sandford D Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandford D Smith owns 8 companies in total, including Akcea Therapeutics Inc (AKCA) , Cytokinetics Inc (CYTK) , and Seneca Biopharma Inc (SNCA) among others .
Click here to see the complete history of Sandford D Smith’s form 4 insider trades.
Insider Ownership Summary of Sandford D Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-12 | director |
| CYTK | Cytokinetics Inc | 2022-09-02 | director |
| SNCA | Seneca Biopharma Inc | 2019-07-01 | director |
| SEEL | Seelos Therapeutics Inc | 2014-08-08 | director |
| NVLNF | Novelion Therapeutics Inc | 2017-01-27 | director |
| AEGR | Aegerion Pharmaceuticals Inc | 2016-11-29 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2008-07-10 | director |
| PALI | Palisade Bio Inc | 2014-05-08 | director |
Sandford D Smith Latest Holdings Summary
Sandford D Smith currently owns a total of 2 stocks. Among these stocks, Sandford D Smith owns 12,170 shares of Cytokinetics Inc (CYTK) as of September 2, 2022, with a value of $788,616 and a weighting of 100%. Sandford D Smith also owns 0 shares of Aegerion Pharmaceuticals Inc (AEGR) as of October 29, 2013, with a value of $0 and a weighting of 0%.
Latest Holdings of Sandford D Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2022-09-02 | 12,170 | 64.80 | 788,616 |
| AEGR | Aegerion Pharmaceuticals Inc | 2013-10-29 | 0 | 1.97 | 0 |
Holding Weightings of Sandford D Smith
Sandford D Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandford D Smith has made a total of 16 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Cytokinetics Inc is the sale of 11,369 shares on September 2, 2022, which brought Sandford D Smith around $613,585.
According to the SEC Form 4 filings, Sandford D Smith has made a total of 0 transactions in Aegerion Pharmaceuticals Inc (AEGR) over the past 5 years. The most-recent trade in Aegerion Pharmaceuticals Inc is the sale of 2,502 shares on October 29, 2013, which brought Sandford D Smith around $237,690.
Insider Trading History of Sandford D Smith
- 1
Sandford D Smith Trading Performance
Sandford D Smith Ownership Network
Ownership Network List of Sandford D Smith
Ownership Network Relation of Sandford D Smith
Sandford D Smith Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Sandford D Smith is the director of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Sandford D Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Sandford D Smith. You might contact Sandford D Smith via mailing address: C/o Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
